U.S.
Anthropic Raises Record $81.3 Billion in Nasdaq IPO as IPOX® Weighs Demand and Valuation
Anthropic priced its Nasdaq IPO on November 18 at $83 per share, above the $70–$78 marketing range, selling an upsized 980 million shares for $81.3 billion in the largest IPO on record. The pricing valued the Claude developer at about $1.5 trillion on a fully diluted basis, and a separate $26 billion private placement took the combined raise to $107.3 billion. The shares began trading under ANT on November 19, and on November 20 Anthropic said its underwriters had exercised the greenshoe option, lifting total IPO proceeds to about $93.5 billion. IPOX® Associate Lukas Muehlbauer told Reuters that part of the demand may reflect investors not wanting to miss a rare chance to own a leading AI company, even as its long-term profitability remains uncertain. IPOX® Vice President Kat Liu told Money.ca that the valuation means growth and profitability will face increasingly close scrutiny, while IPOX® CEO Josef Schuster told Nikkei and the Money Life podcast that he expects the shares to stay volatile until earnings provide a fundamental anchor. (Source 1) (Source 2) (Source 3) (Source 4) (Source 5) (Source 6)
DayOne Pauses Planned Nasdaq IPO Amid Data-Centre Selloff
DayOne Data Centers has put its planned Nasdaq IPO on hold following the selloff in data-centre and AI-related stocks, Bloomberg reported on November 20. The Singapore-based operator filed publicly in October and had aimed to raise up to $5 billion, possibly in the fourth quarter. No final decision has been made, and the company could still list in 2027. (Source 1) (Source 2)
Our Next Energy Agrees $1 Billion Nasdaq SPAC Combination With Wen Acquisition
Our Next Energy (ONE), a Michigan-based maker of lithium iron phosphate batteries, agreed on November 16 to go public through a combination with Wen Acquisition Corp., a Nasdaq-listed SPAC. The transaction values the combined company at about $1 billion, comprising $600 million of pre-money equity and up to $400 million in gross proceeds from the SPAC trust and a private placement. The combined company is expected to trade on Nasdaq under ONEE, with completion targeted for the first half of 2027. (Source 1) (Source 2)
Core Specialty Files for Proposed NYSE IPO
Core Specialty Insurance Holdings filed publicly on November 16 for an IPO on the New York Stock Exchange under the ticker CORE. Existing shareholders will sell all of the offered shares, so the Cincinnati-based specialty insurer will receive no proceeds; the number of shares and price range have yet to be set. Nine-month revenue fell to $2.16 billion from $2.55 billion, while the combined ratio improved to 93% from 98.2%. J.P. Morgan and Goldman Sachs are leading the offering. (Source 1) (Source 2)
U.S. IPO Proceeds Hit a Record as IPOX® Highlights a Selective Reopening
U.S. IPO proceeds in 2026 have surpassed the 2021 record, led by Anthropic’s $81.3 billion offering and SpaceX’s $75 billion listing, Reuters reported on November 19, while the number of new listings remains well below historical highs. Activity slowed in the second half as the AI trade cooled, bond yields rose and rate-hike expectations weighed on sentiment, with several deals pushed into 2027. IPOX® Associate Lukas Muehlbauer told Reuters that the two companies will account for about two-thirds of this year’s proceeds, so the headline figure overstates the breadth of the recovery, and described 2026 as a selective reopening rather than a broad-based revival. (Source 1) (Source 2)
Europe
METKA Prices €300 Million Athens IPO at €10 per Share
METKA, the infrastructure subsidiary of Metlen Energy & Metals, set the final price of its Euronext Athens IPO at €10 per share on November 20, the bottom of its €10–€11.50 range. The offering of 30 million shares, comprising 25 million new shares and 5 million existing shares sold by Metlen, raises about €300 million, including €250 million in new capital for public-private partnership and concession projects, and was more than twice covered. Allocations are due on November 25 and trading is expected to start on November 26, with Metlen retaining a majority stake of about 76%. (Source 1) (Source 2) (Source 3)
Ascend Sport Technology Plans Up to SFr220 Million Offer for SIX Listing
Ascend Sport Technology, a Swiss sports-advertising technology group, plans to list on the SIX Swiss Exchange through a reverse takeover of EvoNext Holding, a listed cash shell. An accompanying offering of 8 million new and 72 million existing shares at SFr2.25–SFr2.75 each would raise up to SFr220 million (about $262 million), with bookbuilding from December 7 to December 10, subject to shareholder approval on December 3. The combined company is expected to start trading under the Ascend name on December 14. (Source 1) (Source 2)
Ponar Wadowice Plans Warsaw IPO to Fund Defence Expansion
Ponar Wadowice, a Polish maker of hydraulics used in military vehicles and howitzers, announced on November 20 that it plans an IPO on the main market of the Warsaw Stock Exchange. The offering combines new shares of up to 5% of share capital with sales by existing shareholders, and Strefa Inwestorów reported that it could exceed 1 billion zlotys (about $247 million). New-share proceeds would complete the purchase of a 51% stake in CASP System and fund PK MIL, a joint venture with Ukraine’s Kramatorsk Heavy Machine Tool Plant to build howitzers in Poland. Chief executive Marek Warzecha will remain the controlling shareholder. (Source 1) (Source 2) (Source 3)
Tommy Seeks Up to €200 Million in Zagreb IPO
Tommy, a Croatian supermarket chain with about 300 stores, is offering about 2.15 million shares at €83–€93 each in a Zagreb Stock Exchange IPO that could raise up to about €200 million. Subscription runs from November 23 to December 4, with trading expected to begin on December 9. Proceeds will fund new stores, acquisitions and investment in its Bobis bakery business. (Source 1) (Source 2) (Source 3)
Hasko Prices SEK1.07 Billion Stockholm IPO
Hasko, a Swedish owner of 17 niche industrial companies, set the price of its Nasdaq Stockholm IPO at SEK38 per B share on November 19, valuing the company at about SEK4.2 billion. The SEK1.07 billion ($105 million) offering includes SEK400 million of new shares, and six cornerstone investors, including the Third Swedish National Pension Fund, have committed SEK800 million. Trading is expected to begin on November 25. (Source 1) (Source 2)
LEO Pharma Owners Hold Off on IPO as Market Conditions Deter Listing
LEO Pharma’s owners consider current market conditions unsuitable for an IPO, chief executive Christophe Bourdon told Reuters on November 16, casting further doubt on a Copenhagen listing in 2026. Bourdon said an IPO remained a “natural and viable option”, with timing in the hands of the LEO Foundation, which owns 80%, and Nordic Capital; Bloomberg reported that the plans had been delayed beyond 2026. No new timetable has been set. (Source 1) (Source 2)
Eurocash Begins Preparations for Possible Frisco IPO in Warsaw
Eurocash said on November 19 that it had begun preparations for a potential Warsaw IPO of Frisco, its online grocery unit, and had selected advisers. A listing would help fund the expansion of Frisco’s automated logistics model, currently operating at two Warsaw warehouses, to other major Polish cities. The final decision, size and timing remain open, and Eurocash is also reviewing other strategic options for the unit. (Source 1) (Source 2) (Source 3)
CloudFerro Weighs Warsaw IPO
CloudFerro, a Polish cloud-infrastructure provider, is considering an IPO in Warsaw that could take place as soon as 2027, Bloomberg reported on November 20, citing people familiar with the matter. JPMorgan, UniCredit and Trigon Dom Maklerski are working on the potential listing. No size or valuation has been disclosed. (Source)
Ellipses Pharma Explores London Listing via Wolfram Reverse Takeover
Ellipses Pharma, a British cancer-drug developer, said on November 18 that it was exploring a London listing through a reverse takeover by Wolfram Resources, a London-listed shell company. The Times reported that Ellipses was targeting a valuation of £450 million–£500 million; deal terms have yet to be agreed. The company aims to complete the transaction by early 2027 and expects to raise equity alongside it. (Source 1) (Source 2)
Airtel Money Trades Above IPO Price as IPOX® Highlights Disciplined Pricing
Airtel Money, the African mobile-money provider that listed in London in October, closed at 226 pence on November 18, about 15% above its 196 pence IPO price, after trading more than 10% below it in its first week, Bloomberg reported. IPOX® Associate Lukas Muehlbauer told Bloomberg that the rebound suggests growing investor confidence in the growth story presented at the IPO, and that issuers who price with discipline leave room for aftermarket gains, a good sign for London as it works to rebuild its IPO pipeline. (Source)
Asia-Pacific
Shenzhou Semiconductor Wins STAR Market Approval for RMB2.18 Billion IPO
Jiangsu Shenzhou Semiconductor Technology won approval from the Shanghai Stock Exchange’s listing committee on November 16 for its proposed STAR Market IPO and filed for registration the following day. The maker of plasma power supplies for semiconductor manufacturing plans to issue up to 22 million shares and targets RMB2.18 billion in proceeds, with Guotai Haitong Securities as sponsor. (Source 1) (Source 2)
Sinotau Launches Up to HK$446 Million Hong Kong IPO Ahead of November 24 Debut
Beijing Sinotau International Pharmaceutical Technology, a developer of diagnostic and therapeutic radiopharmaceuticals, launched a Hong Kong IPO of 6.56 million H shares at HK$52–HK$68 each, for proceeds of up to HK$446 million ($57 million). Pricing was scheduled for November 20, with trading due to begin on November 24. Proceeds will fund research and development, sales and marketing and a new manufacturing facility. (Source 1) (Source 2)
Yuen Kee Food Moves Closer to Hong Kong IPO
Yuen Kee Food Group, the Chinese dumpling chain with more than 4,700 stores, is preparing to start a pre-roadshow for a Hong Kong IPO that could raise more than HK$392 million ($50 million), the South China Morning Post reported on November 20, citing sources. Books could open as early as November 27, with Huatai International and GF Securities as sponsors. (Source)
KK Mart Signs Underwriting Deal Ahead of Bursa Malaysia IPO
KK Mart Retail, which operates nearly 1,000 convenience stores in Malaysia, signed an underwriting agreement with Maybank Investment Bank on November 16 ahead of its Main Market IPO on Bursa Malaysia. The offering comprises 840 million shares, including 630 million existing shares and 210 million new shares. The offer price and listing date have yet to be announced. (Source 1) (Source 2)
Zhejiang Energy Marine Receives CSRC Approval for Hong Kong IPO
Zhejiang Energy Marine Environmental Technology has received approval from the China Securities Regulatory Commission for a Hong Kong IPO of up to 64.69 million H shares, according to a notice published on November 13. The company supplies green shipping equipment, including vessel exhaust-gas cleaning and energy-efficiency systems. The offer size and timetable have not been disclosed. (Source)
Lai Fung Plans Shanghai C-REIT IPO to Repay Offshore Loan
Lai Fung Holdings plans to spin off part of Hong Kong Plaza, its flagship mixed-use property in Shanghai, through a REIT IPO on the Shanghai Stock Exchange, according to a November 18 announcement. The Hong Kong-listed developer, controlled by Lai Sun Development, expects the proceeds to repay a HK$2.47 billion ($315 million) offshore syndicated loan due in March and will retain at least 20% of the REIT units. Lai Fung has yet to apply to the exchange or the CSRC. (Source 1) (Source 2)
China Reportedly Bars Young Red-Chip Firms From Offshore Listings
The China Securities Regulatory Commission (CSRC) has told some law firms it will not approve offshore listings by red-chip companies established after its March 2023 overseas listing rules unless they re-domicile in China, Reuters reported on November 20, citing people familiar with the matter. Red-chip firms are registered abroad but control businesses in China, a structure favoured by Chinese technology start-ups seeking to list in Hong Kong or New York. Reuters said the move could weigh on Hong Kong’s IPO pipeline, where about 600 applications were pending at the end of October; the CSRC did not immediately respond to a request for comment. (Source 1) (Source 2)
MENA
Laprophan’s 2.22 Billion Dirham Casablanca IPO Draws Strong Demand
Laprophan, a Moroccan pharmaceutical group, drew orders of 15.3 billion dirhams ($1.5 billion) for its 2.22 billion dirham (about $220 million) IPO on the Casablanca Stock Exchange, about seven times the amount on offer, lead manager CFG Bank said on November 19. The offering, the largest Casablanca listing this year, combines new and existing shares and attracted 44,000 subscribers; final results are due on November 25. Proceeds will support expansion, including the proposed acquisition of Polymedic. (Source 1) (Source 2) (Source 3)
Misr Life Insurance Plans About $200 Million Egyptian Exchange IPO
Misr Life Insurance, Egypt’s largest life insurer, announced on November 17 its intention to float on the Egyptian Exchange through the sale of 750 million existing shares, about 15% of the company, by Misr Insurance Holding, which is owned by the Sovereign Fund of Egypt. The offering is expected to raise about $200 million, with EFG Hermes as sole global coordinator. Subscription and trading are expected in December, and the insurer targets annual dividends equal to 70% of net income from 2026. (Source 1) (Source 2) (Source 3)
Sub-Saharan Africa
Dangote Refinery IPO Draws About $4.5 Billion in Orders
Dangote Petroleum Refinery plans to increase its Nigerian IPO by up to 30% to about $2.1 billion after receiving orders of nearly 6 trillion naira ($4.5 billion), about three times the shares initially offered, Reuters reported on November 17, citing people involved in the deal. The refinery expects to allot up to 5.33 billion shares rather than the 4.1 billion initially offered, subject to approval from Nigeria’s Securities and Exchange Commission. Retail investors are set to receive their full allocations, with offshore investors bearing most of the scaling back; no listing date has yet been confirmed. (Source 1) (Source 2) (Source 3)
